| 000 | 01217 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250511151912.0 | ||
| 264 | 0 | _c19770425 | |
| 008 | 197704s 0 0 eng d | ||
| 022 | _a0312-5963 | ||
| 024 | 7 |
_a10.2165/00003088-197601010-00003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGugler, R | |
| 245 | 0 | 0 |
_aDrug protein binding and the nephrotic syndrome. _h[electronic resource] |
| 260 |
_bClinical pharmacokinetics _c1976 |
||
| 300 |
_a25-35 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntipyrine _xblood |
| 650 | 0 | 4 |
_aBlood Proteins _xmetabolism |
| 650 | 0 | 4 |
_aClofibrate _xadverse effects |
| 650 | 0 | 4 |
_aDiazepam _xadverse effects |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aNephrotic Syndrome _xblood |
| 650 | 0 | 4 |
_aPharmaceutical Preparations _xblood |
| 650 | 0 | 4 |
_aPhenytoin _xadverse effects |
| 650 | 0 | 4 |
_aPrednisone _xadverse effects |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 |
_aSerum Albumin _xdeficiency |
| 700 | 1 | _aAzarnoff, D L | |
| 773 | 0 |
_tClinical pharmacokinetics _gvol. 1 _gno. 1 _gp. 25-35 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00003088-197601010-00003 _zAvailable from publisher's website |
| 999 |
_c807461 _d807461 |
||